U.S. Markets open in 1 hr 47 mins

Rexahn Pharmaceuticals, Inc. (REXN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2000+0.0200 (+0.92%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.97
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.2600
52 Week Low 31.2600
50-Day Moving Average 32.0753
200-Day Moving Average 32.3645

Share Statistics

Avg Vol (3 month) 356.67k
Avg Vol (10 day) 3126.53k
Shares Outstanding 54.48M
Float 4.22M
% Held by Insiders 10.31%
% Held by Institutions 111.47%
Shares Short (Sep 29, 2020) 413.6k
Short Ratio (Sep 29, 2020) 40.17
Short % of Float (Sep 29, 2020) 40.30%
Short % of Shares Outstanding (Sep 29, 2020) 40.30%
Shares Short (prior month Aug 30, 2020) 41.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 11, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-626.10%

Management Effectiveness

Return on Assets (ttm)-32.23%
Return on Equity (ttm)-67.16%

Income Statement

Revenue (ttm)1.15M
Revenue Per Share (ttm)0.29
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.16M
Net Income Avi to Common (ttm)-6.93M
Diluted EPS (ttm)-2.6580
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.21M
Total Cash Per Share (mrq)2.17
Total Debt (mrq)136.2k
Total Debt/Equity (mrq)1.95
Current Ratio (mrq)3.37
Book Value Per Share (mrq)2.92

Cash Flow Statement

Operating Cash Flow (ttm)-7.1M
Levered Free Cash Flow (ttm)-4.51M